Zivo Bioscience, Inc.
ZIVO· OTC
Filed Nov 14, 2012 · 10-Q · 45 days after period end · 0001078782-12-002847
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $0.00 | $35.65K | $19.29K |
| Net Income | -$560.06K | -$542.35K | -$589.08K |
| EPS Diluted | -$0.01 | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 14, 2012 · 45 d after period end